Pre-exposure prophylaxis (PrEP) resources

In February 2016, Health Canada approved the daily oral use of the antiretroviral drug Truvada, in combination with safer sex practices, for reducing the risk of the sexual transmission of HIV. The approval is an important step towards the wider use of pre-exposure prophylaxis, or PrEP, for HIV prevention in Canada.

While numerous studies have demonstrated that Truvada as PrEP is a highly effective HIV prevention strategy when used consistently and correctly, many service providers are asking for resources to help them communicate PrEP information to clients and communities, and integrate information on PrEP into programs and services.

Here are a number of resources produced by CATIE and other organizations that can help service providers incorporate PrEP into their HIV prevention work.

Resources for service providers and clients to learn about PrEP basics

PrEP information tailored to specific populations

Resources for clients thinking about taking PrEP

Learning how to address PrEP in community-based service delivery

Guidance for PrEP management in clinical settings

These documents outline how PrEP can be managed in clinical settings. They include recommendations on who should be using PrEP and the prescription, monitoring and discontinuation of PrEP.